HIV Pre-Exposure Prophylaxis: What Do Pediatricians Need to Know?

Stephanie P. Ungar, Michal Paret, Gail F. Shust

Research output: Contribution to journalArticlepeer-review

Abstract

Pediatricians and adolescent providers play an important role in the health and well-being of adolescents and young adults, including their sexual health. HIV remains an ongoing concern for young people, with 21% of new HIV diagnoses occurring in this age group. The use of antiretroviral therapy for pre-exposure prophylaxis (PrEP) to prevent transmission of HIV to people who are not infected has been proven safe and effective. PrEP can be considered as part of a comprehensive risk mitigation strategy for adolescents and young adults, with clear guidelines for baseline evaluation and ongoing man-agement.

Original languageEnglish
Pages (from-to)e191-e195
JournalPediatric Annals
Volume51
Issue number5
DOIs
StatePublished - May 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'HIV Pre-Exposure Prophylaxis: What Do Pediatricians Need to Know?'. Together they form a unique fingerprint.

Cite this